Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study
Idiopathic pulmonary fibrosis (IPF) is a progressive and inevitably fatal disease with a heterogeneous clinical course. This study aimed to evaluate the usefulness of circulating biomarkers in routine IPF clinical practice. We conducted an exploratory study in a cohort of 28 IPF subjects qualified f...
Main Authors: | Sebastian Majewski, Karolina Szewczyk, Aleksandra Żal, Adam J. Białas, Joanna Miłkowska-Dymanowska, Wojciech J. Piotrowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/17/3864 |
Similar Items
-
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis
by: Piera Soccio, et al.
Published: (2024-01-01) -
Identifying the link between serum VEGF and KL-6 concentrations: a correlation analysis for idiopathic pulmonary fibrosis interstitial lung disease progression
by: Bin Zhong, et al.
Published: (2023-12-01) -
Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis
by: Luis Placido, et al.
Published: (2021-03-01) -
Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features—What Do We Already Know?
by: Ewa Miądlikowska, et al.
Published: (2021-12-01) -
Correlation between serum KL-6 level and severity of SARD-related ILD
by: Emmy Pranggono, et al.
Published: (2022-04-01)